Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies and products, has filed a Patent Cooperation Treaty (“PCT”) that seeks international protection of its proprietary cannabinoid infusion system for beverages, foods and consumer products. The PCT is aimed at seeking patent protections for inventions resulting from CBGL’s Project Varin research program. Specifically, the application relates to innovative methods for the creation of highly bioavailable and ultra-fast-acting cannabinoids for use in beverages, food, topicals and other applications. Noting that this technology is revolutionary, the company believes its breakthrough research could potentially result in substantial cost reductions and efficacy enhancements, as well as significantly faster onset of active cannabinoids ingredients. “At Cannabis Global we hold the opinion that not only will cannabis be soon descheduled and legalized within the United States, but in many other areas of the world,” said Cannabis Global CEO Arman Tabatabaei. “It is important for our company to start on the PCT process as soon as is possible to ensure we will be able to capitalize on the expected wave of global cannabis legalization, especially relating to Southeast Asia and within the European Union where legalization and decriminalization is already well underway.”
To view the full press release, visit https://cnw.fm/IiIXZ
About Cannabis Global Inc.
Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp- and cannabis-infusion technologies. The company does not engage in the production, distribution or sales of any controlled substances, including marijuana. CBGL has an actively growing portfolio of intellectual property, having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, designed to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (“THV-C”) and to develop products based on this cannabinoid. For more information about the company, visit www.CannabisGlobalInc.com.
NOTE TO INVESTORS: The latest news and updates relating to CBGL are available in the company’s newsroom at http://cnw.fm/CBGL
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire is part of the InvestorBrandNetwork.